Skip to main content

Table 2 Univariate and multivariate Cox regression analyses of clinicopathologic variables of patients with early-stage cervical squamous cell cancer for overall survival

From: The expression and prognostic value of protein tyrosine kinase 6 in early-stage cervical squamous cell cancer

Variable

Univariate analysis

Multivariate analysis

HR

95% CI

P value

HR

95% CI

P value

Age (>45 vs. ≤45 years)

2.906

0.911–9.268

0.071

   

Tumor size (>4 vs. ≤4 cm)

0.608

0.239–1.545

0.295

   

Tumor grade (1 + 2 vs. 3)

1.239

0.446–3.441

0.681

   

SCC antigen level (>1.5 vs. ≤1.5 ng/mL)

1.477

0.512–4.264

0.471

   

FIGO stage (IB1 + IB2 + IIA1 vs. IIB)

2.111

1.313–3.392

0.002

2.876

1.582–5.229

0.001

Pelvic lymph node metastasis (present vs. absent)

3.569

1.237–10.294

0.019

0.291

0.047–1.789

0.183

Deep cervical stromal invasion (present vs. absent)

5.385

1.205–24.065

0.028

1.548

0.266–8.999

0.626

Lymphovascular space invasion (present vs. absent)

13.212

4.575–38.156

<0.001

19.284

5.958–62.419

<0.001

PTK6 expression (high vs. low)

4.763

1.326–17.112

0.017

5.999

1.622–22.191

0.007

  1. HR hazard ratio, CI confidence interval, SCC squamous cell carcinoma